AWM
NVCR icon

Avior Wealth Management’s NovoCure NVCR Stock Holding History

Avior Wealth Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-60
Closed -$13K – 1140
2021
Q2 		$13K Hold
60
– – ﹤0.01% 712
2021
Q1 		$7K Hold
60
– – ﹤0.01% 807
2020
Q4 		$10K Hold
60
– – ﹤0.01% 714
2020
Q3 		$6K Hold
60
– – ﹤0.01% 738
2020
Q2 		$3K Hold
60
– – ﹤0.01% 768
2020
Q1 		$4K Hold
60
– – ﹤0.01% 648
2019
Q4 		$5K Buy
+60
New +$4.84K ﹤0.01% 656

Other funds holding NVCR

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avior Wealth Management's NVCR Position: Q3 2021 in Review

Avior Wealth Management sold out of NovoCure (NVCR) in Q3 2021, closing a stake of 60 shares — an estimated $13K sold.

Avior Wealth Management first reported a position in NVCR in Q4 2019 and held it in 7 quarters. The position peaked at $13K in Q2 2021. 317 funds tracked by Wall St. Rank hold NVCR as of Q3 2021.

  • Avior Wealth Management reported no remaining NovoCure position as of Q3 2021 after selling out during the quarter.
  • Avior Wealth Management sold 60 NovoCure shares in Q3 2021, an estimated $13K.
  • Avior Wealth Management first reported a position in NovoCure in Q4 2019 and held it in 7 quarters.
  • Avior Wealth Management's NovoCure position peaked at $13K in Q2 2021.
  • 317 funds tracked by Wall St. Rank held NovoCure as of Q3 2021.

Based on Avior Wealth Management's 13F filing for Q3 2021, filed 2 Nov 2021.